{
  "title": "Cell Therapy Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)",
  "slug": "cell-therapy-market",
  "industry": "Biotechnology & Genomics",
  "parent_industry": "Healthcare (Pharma, Medical Devices, Biotech)",
  "url": "https://www.mordorintelligence.com/industry-reports/cell-therapy-market",
  "scraped_at": "2026-09-17T17:44:51+07:00",
  "dataset_properties": [
    {
      "@type": "PropertyValue",
      "name": "Market Size (2026)",
      "value": 6.55,
      "unitText": "USD Billion"
    },
    {
      "@type": "PropertyValue",
      "name": "Market Size (2031)",
      "value": 14.56,
      "unitText": "USD Billion"
    },
    {
      "@type": "PropertyValue",
      "name": "Growth Rate (2026 - 2031)",
      "value": 17.32,
      "unitText": "PERCENT"
    },
    {
      "@type": "PropertyValue",
      "name": "Fastest Growing Market",
      "value": "Asia Pacific"
    },
    {
      "@type": "PropertyValue",
      "name": "Largest Market",
      "value": "North America"
    },
    {
      "@type": "PropertyValue",
      "name": "Market Concentration",
      "value": "Medium"
    }
  ],
  "faq": [
    {
      "@type": "Question",
      "name": "How large is the cell therapy market in 2026?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The cell therapy market size reached USD 6.55 billion in 2026 and is projected to climb to USD 14.56 billion by 2031."
      }
    },
    {
      "@type": "Question",
      "name": "Which type of therapy is growing fastest?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Allogeneic, off-the-shelf therapies are the fastest, advancing at a 17.34% CAGR through 2031 due to lower cost-of-goods and shorter manufacturing lead times."
      }
    },
    {
      "@type": "Question",
      "name": "What region will post the highest growth?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Asia-Pacific is expected to deliver the highest regional CAGR of 17.89% as China, Japan, and South Korea streamline approvals and expand reimbursement."
      }
    },
    {
      "@type": "Question",
      "name": "What is the main cost challenge for autologous CAR-T?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Personalized production averages USD 350,000 per dose and involves high fixed GMP costs, pressuring margins and affordability."
      }
    },
    {
      "@type": "Question",
      "name": "How are manufacturers reducing costs?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "AI-optimized closed bioreactors, capacity expansion at CDMOs, and non-viral gene-delivery methods are cutting per-dose costs significantly."
      }
    },
    {
      "@type": "Question",
      "name": "Which application segment is expanding fastest?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Neurological disorders lead with a 17.47% CAGR, fueled by late-stage trials in Parkinson's disease using iPSC-derived neurons."
      }
    }
  ],
  "images": [
    "images/cell-therapy-market-size-image-1776063376867.png",
    "images/cell-therapy-market_1668583136149_cell_th.png",
    "images/cell-therapy-market-Cell-Therapy-Market-Market-Share-by-Therapy-Type-2025-1767693612371.png",
    "images/cell-therapy-market-Cell-Therapy-Market-Market-Share-by-Application-2025-1767765286668.png",
    "images/cell-therapy-market-Cell-Therapy-Market-CAGR--Growth-Rate-by-Region-2026---2031-1767766750380.png",
    "images/cell-therapy-market-competitive-landscape-1767694092078.png",
    "images/market-snapshot.png",
    "images/Esomar-25.png",
    "images/GPTW-25-3xl.png",
    "images/cell-therapy-market-size-image-1776063376867.png"
  ],
  "sections_count": 15
}